Soleno Therapeutics (SLNO) Preferred Dividend Payments (2015 - 2016)
Soleno Therapeutics' (SLNO) quarterly Preferred Dividend Payments came in at $3.7 million in Q4 2016, up 219.71% year-on-year from $1.1 million in Q1 2016, and little changed on a QoQ basis from $3.7 million in Q3 2016.
Soleno Therapeutics (SLNO) Preferred Dividend Payments (2015 - 2016) Analysis & Trends
Soleno Therapeutics (SLNO) has 2 years of Preferred Dividend Payments data on file, last reported at $3.7 million in Q4 2016.
- On a quarterly basis, Preferred Dividend Payments rose 219.71% year-over-year to $3.7 million in Q4 2016; TTM through Dec 2016 was $7.3 million, a N/A change from a year earlier, with the FY2016 full-year figure at $3.7 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q4 2016 stood at $3.7 million, roughly flat from $3.7 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for SLNO reached as high as $3.7 million in Q4 2016 and fell as low as -$3.0 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 3.65 Mn |
| Sep 30, 2016 | 3.65 Mn |
| Dec 31, 2015 | -3.05 Mn |
| Mar 31, 2015 | 3.05 Mn |